Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2007 1
2008 4
2009 5
2010 9
2011 5
2012 2
2013 3
2014 5
2015 13
2016 10
2017 10
2018 10
2019 12
2020 12
2021 9
2022 16
2023 19
2024 18
2025 11
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ter van laar (4 results)?
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.
Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A. Katzenschlager R, et al. Among authors: van laar t. Lancet Neurol. 2018 Sep;17(9):749-759. doi: 10.1016/S1474-4422(18)30239-4. Epub 2018 Jul 25. Lancet Neurol. 2018. PMID: 30055903 Clinical Trial.
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years: A Nonrandomized Controlled Trial.
Jost ST, Aloui S, Evans J, Ashkan K, Sauerbier A, Rizos A, Petry-Schmelzer JN, Gronostay A, Fink GR, Visser-Vandewalle V, Antonini A, Silverdale M, Timmermann L, Martinez-Martin P, Chaudhuri KR, Dafsari HS; International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group and EUROPAR. Jost ST, et al. JAMA Netw Open. 2024 Jan 2;7(1):e2352177. doi: 10.1001/jamanetworkopen.2023.52177. JAMA Netw Open. 2024. PMID: 38236600 Free PMC article. Clinical Trial.
Pharmacogenetics in advanced Parkinson's disease.
Kulisevsky J, García-Ruíz P, Outeiro TF, Gurevich T, Klivènyi P, Van Laar T, Milanov I, Pirker W, Popescu BO, Toft M, Szász JA. Kulisevsky J, et al. Among authors: van laar t. J Neural Transm (Vienna). 2025 Nov;132(11):1719-1726. doi: 10.1007/s00702-025-03057-0. Epub 2025 Nov 12. J Neural Transm (Vienna). 2025. PMID: 41222708 Review.
Supine MDS-UPDRS-III Assessment: An Explorative Study.
Kremer NI, Smid A, Lange SF, Mateus Marçal I, Tamasi K, van Dijk JMC, van Laar T, Drost G. Kremer NI, et al. Among authors: van laar t. J Clin Med. 2023 Apr 25;12(9):3108. doi: 10.3390/jcm12093108. J Clin Med. 2023. PMID: 37176549 Free PMC article.
161 results